Table 4.

Change of proteins in three brain regions from AD patients.^a

Accession	Description	Ratio IF	Ratio SF	Ratio CRLM
P04271	Protein S100-B	2.03	1.94	0.71
P05067	Amyloid beta A4 protein	1.89	1.81	n/a
P14136	Glial fibrillary acidic protein	1.82	1.59	n/a
P00738	Haptoglobin	1.82	1.94	0.63
P60201	Myelin proteolipid protein	1.80	1.78	n/a
P13611	Versican core protein	1.74	1.56	n/a
P01857	Ig gamma-1 chain C region	1.61	0.64	0.59
P01876	Ig alpha-1 chain C region	1.57	1.60	n/a
P01024	Complement C3	1.43	1.42	n/a
P15104	Glutamine synthetase	0.68	n/a	0.75
P08670	Vimentin	0.67	0.69	n/a
P11137	Microtubule-associated protein 2	0.64	0.58	n/a
Q6PUV4	Complexin-2	0.54	0.49	0.59
O14810	Complexin-1	0.48	0.51	n/a
P01009	Alpha-1-antitrypsin	n/a	n/a	0.66
P02671	Fibrinogen alpha chain	n/a	1.45	0.64
P01871	Ig mu chain C region	n/a	0.59	0.64

n/a: The protein was not differentially regulated in this brain region.

IF – Inferior frontal, SF – Superior frontal, CRLM – Cerebellum.

^aThe proteins in the table are differentially regulated proteins from three brain areas in at least 2 out of 5 AD patients when comparing each AD relative to the average of 5 controls.